FDA calls for investigation into industry influence during Alzheimer's drug approval
BMJ
.
2021 Jul 12:374:n1778.
doi: 10.1136/bmj.n1778.
Author
Owen Dyer
1
Affiliation
1
Montreal.
PMID:
34253567
DOI:
10.1136/bmj.n1778
No abstract available